Proinflammatory Cytokine Effects on Mesenchymal Stem Cell Therapy for the Ischemic Heart

Aaron M. Abarbanell, Arthur C. Coffey, John W. Fehrenbacher, Daniel J. Beckman, Jeremy L. Herrmann, Brent Weil, Daniel R. Meldrum

Research output: Contribution to journalReview article

52 Scopus citations

Abstract

Mesenchymal stem cells (MSCs) hold great promise for improving myocardial recovery after ischemia. The cardiothoracic surgeon is uniquely positioned to be at the forefront of any clinical application of this therapy. As such, a basic understanding of stem cells and the cytokines that affect stem cell function will be an essential component of the surgeon's ever-expanding knowledge base. This review provides: (1) a general overview of stem cells and MSCs in particular, (2) critically analyzes several cytokines known to alter MSC function, and (3) discusses methods to manipulate cytokine-activated MSCs to improve MSC function for potential clinical application.

Original languageEnglish (US)
Pages (from-to)1036-1043
Number of pages8
JournalAnnals of Thoracic Surgery
Volume88
Issue number3
DOIs
StatePublished - Sep 1 2009

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Proinflammatory Cytokine Effects on Mesenchymal Stem Cell Therapy for the Ischemic Heart'. Together they form a unique fingerprint.

  • Cite this

    Abarbanell, A. M., Coffey, A. C., Fehrenbacher, J. W., Beckman, D. J., Herrmann, J. L., Weil, B., & Meldrum, D. R. (2009). Proinflammatory Cytokine Effects on Mesenchymal Stem Cell Therapy for the Ischemic Heart. Annals of Thoracic Surgery, 88(3), 1036-1043. https://doi.org/10.1016/j.athoracsur.2009.02.093